Table 3: Fertility-sparing treatment cohort (N = 33), demographics and clinical characteristics of patients with continued fertility sparing treatment versus subsequent definitive treatment.
|
|
Overall N = 33 |
Fertility Sparing Treatment Continued n = 27 (81.8%) |
Subsequent Definitive Treatment n = 6 (18.2%) |
P value |
|
Age at diagnosis (yrs), Median (IQR) |
34.4 (30.2-36.5) |
34.4 (30.3-36.5) |
32.3 (29.2-38.2) |
0.76 |
|
Stage, N (%) IA1 IA2 IB1 |
25 (75.8) < 5 < 5 |
19 (70.4) < 5 < 5 |
6 (100.0) < 5 < 5 |
0.43† |
|
Histology, N (%) Adenocarcinoma Squamous |
14 (42.4) 19 (57.6) |
10 (37.0) 17 (63.0) |
< 5 < 5 |
0.36† |
|
Race/ethnicity, N (%) Asian Hispanic White Non-Hispanic White Other/Unknown |
7 (21.2) 5 (15.2) 19 (57.6) < 5 |
6 (22.2) < 5 15 (55.6) < 5 |
< 5 < 5 < 5 < 5 |
> 0.99† |
|
BMI (kg/m2), Median (IQR) |
26.4 (21.8-29.0) |
27.6 (22.8-32.3) |
21.4 (18.1-26.4) |
0.05 |
|
Neighborhood Deprivation Index, N (%) Q1 (Least Deprived) Q2 Q3 Q4 (Most Deprived) |
5 (15.2) 16 (48.5) < 5 8 (24.2) |
< 5 13 (48.2) < 5 7 (25.9) |
< 5 < 5 < 5 < 5 |
> 0.99† |
|
Parity, N (%) Nulliparous Parous |
19 (57.6) 14 (42.4) |
16 (59.3) 11 (40.7) |
< 5 < 5 |
>0.99† |
Wilcoxon performed on continuous variables that are not normally distributed. Some cells may have exact frequencies and percentages suppressed due to small cell size.
†: Fisher’s Exact performed on categorical variables with cell counts less than 5.